Equitybee vs EquityZen 2026
Both platforms appear in the same search for “invest in pre-IPO companies,” and both are accredited-only. That is where the resemblance ends. EquityZen generally sells SPV interests backed by actual company shares through a secondary marketplace; Equitybee sells you a contingent claim on one employee’s option proceeds and finances their exercise. This guide compares what the primary-source data — Form D filings, the templated PPM, Form ADV, and 21 live offers — actually shows.
Guide Thesis
EquityZen gives you exposure to the company’s shares. Equitybee gives you a claim on one employee’s bet on it.
EquityZen: Morgan Stanley-owned, 2.5% fee, SPV interest in real shares, K-1, multi-year illiquidity, ROFR risk. Equitybee: option-exercise funding, a contingent claim (not shares), ~10% fee stack plus a 17-42% capped Share Incentive, unaudited series, total-loss floor.
The real comparison isn’t which platform has the hotter companies. It’s whether you want to own a slice of the company’s shares (EquityZen) or finance an employee’s option exercise for a capped share of the upside (Equitybee).
EquityZen: SPV interest in real shares, 2.5% fee, full appreciation net of fees. Equitybee: a contingent financing claim, ~10% fees plus a 17-42% employee Share Incentive, zero floor if no liquidity event occurs.
Who each platform is for
EquityZen
- 👤 WhoAccredited investors only (net worth $1M+ or income $200K+)
- 💵 Entry$5,000 minimum (post-2026); $50,000 standard single-company fund
- 🎯 GoalOwn an interest in actual pre-IPO shares via SPV
- 📄 TaxK-1 — timing varies by vehicle (early March to Aug/Sept)
- ⚠️ KnowROFR can kill a deal post-commitment; 74% return is survivorship-biased
- ✅ Best forInvestors wanting share exposure at the lowest visible fee (2.5%)
Equitybee
- 👤 WhoAccredited investors only — narrower fit
- 💵 EntryGenerally $10,000 minimum per series (varies by offer)
- 🎯 GoalFinance an employee's option exercise for a capped equity share
- 📄 TaxK-1 — generally after April 15 (extension is the default)
- ⚠️ KnowContingent claim, not shares; unaudited; 0.00x floor on no event
- ✅ Best forInvestors who specifically want option-funding and can lock up indefinitely

The Core Decision
Shares, or a claim on someone else’s shares.
EquityZen gives you an SPV interest in actual company shares for a 2.5% fee, with full appreciation net of fees — subject to ROFR, lockups, K-1 timing, and a survivorship-adjusted track record. Equitybee gives you a contingent claim on one employee’s proceeds: principal back, 2-4% interest, and a capped 17-42% Share Incentive, net of a ~10% fee stack, with a zero floor if no liquidity event occurs. Both require reading the deal documents — for Equitybee, the dashboard and Form D, because the PPM is a template.
What you own
Different instruments
EquityZen: SPV membership interest in actual company shares. Equitybee: a contingent claim on one employee's future proceeds — never shares, never on the cap table.
Upfront cost
EquityZen 2.5%
2.5% buyer fee post-Morgan Stanley, no carry on single-company SPVs. Equitybee: ~10% platform fees (5% front-end + 5% carry) before the unquantified Stock Appreciation Amount.
Upside
Full vs a sliver
EquityZen: full share appreciation, net of fees. Equitybee: principal + 2-4% interest + a 17-42% Share Incentive — the employee keeps the rest of the appreciation.
TL;DR
The comparison in two sentences
EquityZen is a Morgan Stanley-owned pre-IPO secondary marketplace where you buy an SPV interest in actual company shares at a 2.5% fee — institutional credibility and the lowest visible cost among major platforms, but with ROFR deal-failure risk, multi-year illiquidity, K-1 timing complexity, and a platform-stated 74% return that is survivorship-biased. Equitybee is not a marketplace and holds no shares for you: it finances an employee’s option exercise through an unaudited, fiduciary-duty-waived Series LLC, and you receive principal, 2-4% interest, and a capped 17-42% Share Incentive on a successful event — net of a ~10% fee stack, with a 0.00x total-loss floor if no event occurs.
If you read nothing else: jump to the head-to-head sections →
EquityZen: what the data shows
- → SPV interest backed by actual shares; direct shares at $200K+
- → 2.5% buyer fee (post-Morgan Stanley, Feb 2026); ~5% total friction
- → Platform-stated 74% net aggregate exit return (survivorship-biased)
- → ROFR can block a deal after you commit; 2-5+ year illiquidity
- → 150 Form D SPVs, $230.8M from 4,848 investors (AltStreet data)
Equitybee: what the data shows
- → Contingent claim on one employee’s proceeds — never shares
- → 5% front-end + 5% carry + Stock Appreciation Amount (~10% before SAA)
- → Employee keeps a 17-42% Share Incentive — upside is capped
- → Unaudited series, affiliate-administered, fiduciary duties waived
- → Marketed 70% discount vs ~30% verified to 409A common; 0.00x floor
Quick decision
If you want to own pre-IPO shares
EquityZen
You hold an SPV interest in actual company shares (or direct shares at $200K+), at the lowest visible fee in the secondary market. Underwrite it as a multi-year illiquid private placement with ROFR and K-1 complexity.
If you want the option-funding structure
Equitybee
You finance one employee's exercise for a capped 17-42% equity share plus 2-4% interest. Appropriate only if you accept the ~10% fee stack, the unaudited series, and the total-loss floor — and read the dashboard and Form D, not the 70% headline.
If you prioritize lower cost and credibility
EquityZen
2.5% vs ~10%, Morgan Stanley ownership, a SIPC-member broker-dealer, and an SPV interest backed by real shares rather than a contingent claim. The cheaper, more conventional instrument for most accredited investors.
2.5% vs ~10%
Upfront/recurring platform fee — EquityZen vs Equitybee
EquityZen: 2.5% buyer (2.0% above $1M), no carry on single-company SPVs. Equitybee: 5% front-end brokerage + 5% carried interest, before a separately-defined Stock Appreciation Amount the templated PPM does not quantify.
17–42%
Share Incentive the Equitybee employee retains — caps investor upside
Observed across 21 live offers (June 2026): Figure.ai 17% to Replit 42%, clustering 20-28%; platform-stated range 20-45%. Not a fee — it is the portion of equity value the investor does not receive. Platform-reported.
74%
EquityZen platform-stated net aggregate exit return — survivorship-biased
Excludes ongoing holdings, failed positions, and time-value. ~11.7% annualized before fees over a five-year hold, ~11.1% after the 2.5% fee. Outcome distribution behind the aggregate is not disclosed.
0.00x
Equitybee bankruptcy outcome — the total-loss floor
From Equitybee's own platform-reported MOIC-by-outcome table (44.8-month average for the bankruptcy case), alongside tender/secondary 2.6x, SPAC 1.7x, IPO 1.6x, M&A 1.5x. Repayment is contingent on a successful event and on the individual employee performing; interest compounds only on success.
At a glance
Side-by-side at a glance
| Feature | EquityZen | Equitybee |
|---|---|---|
| Platform type | Pre-IPO secondary marketplace | Pre-IPO employee stock-option funding platform (states it is not a secondary market) |
| What you own | SPV membership interest in actual shares (direct shares at $200K+) | Series LLC interest = a contingent claim on one employee's proceeds |
| Cap-table presence | Indirect via SPV; direct for large buyers | None — the employee remains the legal shareholder |
| Regulatory structure | Reg D, accredited only; SPV LLCs | Reg D 506(c), accredited only; Section 3(c)(1)/3(c)(7) Series LLCs |
| Minimum investment | $5,000 (post-2026 floor); $50,000 standard single-company; $200K+ direct | Generally $10,000 per series (varies by offer) |
| Upfront fee | 2.5% buyer (up to $1M), 2.0% above; sellers pay 2.5% | 5% front-end brokerage on capital contribution at closing |
| Back-end / carry | None on single-company SPVs | 5% carried interest on interest + equity-share portions; + Stock Appreciation Amount |
| Upside structure | Full share appreciation, net of fees | Capped: principal + 2-4% interest + 17-42% Share Incentive |
| Tax document | K-1 (timing varies by vehicle: early March to Aug/Sept) | K-1 (generally after April 15 — extension is the default) |
| Audit / governance | SPVs are limited-disclosure; Morgan Stanley-owned, SIPC-member BD | Unaudited series, affiliate-administered, fiduciary duties waived; BD record clean |
| Corporate backing | Morgan Stanley Wealth Management (acquired Jan 2026) | Equitybee Inc (founded 2017, CEO Oren Barzilai) |
| Broker-dealer | EquityZen Securities LLC (FINRA CRD 281820), SIPC-member | Equitybee Securities LLC (FINRA CRD 41896), no disclosed FINRA enforcement |
| Liquidity / exit | 2-5+ yr; post-IPO lockup; ROFR can block deals; conditional Express Deals | 7-yr term, extendable indefinitely; no redemption, no secondary market |
| Headline vs verified | 74% net aggregate exit return (survivorship-biased) | 70% discount marketed vs ~30% verified to 409A common (21 live offers) |
Final read
Bottom Line Up Front
For most accredited investors who want pre-IPO exposure, EquityZen is the more conventional instrument: an SPV interest backed by actual shares, the lowest visible fee in the secondary market, and Morgan Stanley ownership — with the ROFR, lockup, K-1, and survivorship caveats treated as diligence inputs, not deal-breakers. Equitybee is a narrower, more specialized instrument. It is not a cheaper or more expensive version of EquityZen; it is a different thing — a contingent financing claim on one employee’s proceeds, with a capped upside, a ~10% fee stack, and a zero floor.
The structural insight from primary sources: both platforms surface their economically decisive terms outside the headline pitch. EquityZen’s 74% figure is survivorship-adjusted and its real friction (ROFR, lockup, K-1 timing) lives in the deal documents. Equitybee’s decisive terms — company, price, Share Incentive, and interest rate — are not in the templated PPM at all; they appear only on the authenticated dashboard and the series’ Form D. On either platform, the product page is not the disclosure document.
EquityZen: who should consider it
Accredited investors who want exposure to actual pre-IPO shares through an SPV at the lowest visible fee, can hold for years, can diversify across positions, and are comfortable with SPV structure, K-1 complexity, ROFR deal-failure risk, and delayed liquidity. Investors who value Morgan Stanley’s institutional backing and SIPC-member broker-dealer. Anyone underwriting the 74% figure as survivorship-adjusted rather than expected.
Equitybee: who should consider it
Accredited investors who specifically want the option-funding structure (a contingent claim, not shares), have read the dashboard terms and the series’ Form D, underwrite the portfolio company independently, accept the fee stack and total-loss floor, treat the capped Share Incentive as the realistic ceiling, and can build a diversified basket across many series with capital they can lock up indefinitely. Not for investors who want to own shares, need any defined liquidity timeframe, require audited NAV, or are anchoring on the 70% discount rather than the verifiable ~30% to 409A common.
Comparison hub
Head-to-head decision map
Five dimensions where the platforms diverge most sharply — sourced from primary SEC documents and live offer capture.
Each section isolates a decision dimension that the platforms’ shared “invest in pre-IPO companies” marketing obscures. The data is from Form D filings, the templated cFund Master PPM, Form ADV, FINRA records, and 21 live Equitybee offers captured June 2026 — not from the product pages.
SPV interest in real shares vs a contingent financing claim
Equitybee vs EquityZen: What You Actually Own
This is the difference that defines the comparison, and it is absent from both platforms' marketing convergence around 'invest in pre-IPO companies.' EquityZen is a secondary marketplace: an existing shareholder sells, an accredited buyer buys, and actual shares change hands — usually wrapped in an SPV LLC whose membership interest you hold (or, for $200,000+ direct acquisitions, your name on the cap table). Equitybee is explicitly not a secondary market. It finances a specific employee's option-exercise cost through a single-purpose Series LLC; the employee exercises, keeps 100% legal ownership of the shares, and contractually owes the series principal, 2-4% annual interest, and a 17-42% share of the equity value at a successful liquidity event. You are buying a convertible-loan-plus-equity-participation claim against an individual, not company stock.
Practical answer
If your goal is to hold an interest in a pre-IPO company's equity, EquityZen is the structurally direct path. Equitybee is a financing instrument with equity-like upside participation — appropriate only for an investor who specifically wants that structure and understands the company is not a participant in the offering, the investor never reaches the cap table, and repayment is doubly contingent on both a company event and the individual employee performing.
| Decision factor | What changes |
|---|---|
| Instrument | EquityZen: SPV membership interest in actual shares (or direct shares at $200K+). Equitybee: Series LLC interest = a contingent claim on one employee's proceeds. |
| Cap-table presence | EquityZen: indirect via SPV; direct for large direct-share buyers. Equitybee: none — the employee remains the legal shareholder; the investor never appears on the cap table. |
| Company involvement | EquityZen: company approves the transfer via ROFR. Equitybee: company is not a participant and has not endorsed the offering. |
| What drives your return | EquityZen: the company's share appreciation, net of fees. Equitybee: principal + 2-4% interest + a 17-42% slice of the funded shares' appreciation — the employee keeps the remainder. |
2.5% upfront vs ~10% plus a 17-42% capped upside
Equitybee vs EquityZen: Fees
The visible cost gap is large, and the Equitybee stack is layered in a way the product page does not fully convey. EquityZen charges 2.5% on investments up to $1M (2.0% above), sellers pay 2.5%, and there is no carried interest or ongoing management fee on single-company SPVs — roughly 5% total transaction friction. Equitybee charges a 5% front-end brokerage fee on the capital contribution at closing (to affiliate Equitybee Securities LLC, regardless of outcome), a 5% carried interest on the interest and equity-share portions of proceeds (not on returned principal), and a separately-defined Stock Appreciation Amount that the templated PPM names but does not quantify — roughly 10% in platform fees before that amount. Equitybee's management fee is 0%. Distinct from all of this, the funded employee retains a 17-42% Share Incentive: not a fee, but the portion of equity value the investor does not receive.
Practical answer
On upfront and recurring cost, EquityZen is materially cheaper: a $50,000 investment wires $51,250 and the investor keeps the full appreciation net of that 2.5%. The more important point for Equitybee is structural: the combination of a ~10% fee load and a capped 17-42% Share Incentive means the investor's realistic upside ceiling is a fraction of the company's appreciation, while the downside floor is total loss. The fee comparison is not just 2.5% vs ~10% — it is full appreciation minus 2.5% vs a capped slice of appreciation minus ~10%.
| Decision factor | What changes |
|---|---|
| Upfront / brokerage fee | EquityZen: 2.5% buyer (up to $1M), 2.0% above. Equitybee: 5% front-end brokerage on the capital contribution at closing, paid regardless of outcome. |
| Carried interest | EquityZen: none on single-company SPVs. Equitybee: 5% carry on the interest and equity-share portions of proceeds (not on returned principal). |
| Management fee | EquityZen: none on single-company SPVs (multi-company funds may add costs). Equitybee: 0%. |
| Other | EquityZen: $500 termination fee if an investor fails to complete; sellers pay 2.5%. Equitybee: a separately-defined Stock Appreciation Amount to the Organizer, named but not quantified in the templated PPM; employee retains a 17-42% Share Incentive. |
Full appreciation vs a capped slice — and two headline numbers to discount
Equitybee vs EquityZen: Returns & Upside
Both platforms lead with a headline figure that needs adjustment. EquityZen reports a platform-stated 74% net aggregate exit return, which carries survivorship bias — it excludes ongoing holdings, failed positions, and time-value, and works out to roughly 11.7% annualized before fees over a five-year hold. Equitybee markets a median 70% discount measured against the most recent preferred price; on the 21 current live offers the verifiable discount to 409A common is closer to 30%. The deeper difference is the shape of the payoff. An EquityZen investor receives the full share appreciation net of fees. An Equitybee investor receives principal back, 2-4% interest, and a 17-42% Share Incentive — a capped participation. Equitybee's own platform-reported MOIC-by-outcome table puts tender/secondary at 2.6x, SPAC at 1.7x, IPO at 1.6x, M&A at 1.5x, and bankruptcy at 0.00x.
Practical answer
EquityZen offers uncapped (but fee- and illiquidity-dragged) equity upside with a disclosed total-loss tail. Equitybee offers a capped upside and a zero floor, with the realistic ceiling being the Share Incentive net of the fee stack rather than the company's full appreciation. Use the verifiable ~30% discount for Equitybee and read the 74% EquityZen figure as survivorship-adjusted, not expected.
| Decision factor | What changes |
|---|---|
| Upside shape | EquityZen: full share appreciation, net of ~2.5% fees and illiquidity drag. Equitybee: capped at a 17-42% Share Incentive plus 2-4% interest, net of the ~10% fee stack. |
| Headline figure | EquityZen: platform-stated 74% net aggregate exit return (survivorship-biased). Equitybee: marketed median 70% discount to most-recent preferred. |
| Verified / adjusted | EquityZen: ~11.7% annualized before fees, ~11.1% after, distribution undisclosed. Equitybee: ~30% median discount to 409A common across 21 live offers (range ~6-49%). |
| Downside floor | EquityZen: 100% loss possible if the company fails. Equitybee: explicit 0.00x bankruptcy outcome; interest compounds only on a successful event. |
Morgan Stanley-owned BD vs unaudited, fiduciary-waived series
Equitybee vs EquityZen: Governance & Audit
Both platforms operate clean broker-dealers; the divergence is at the vehicle level. EquityZen runs through EquityZen Securities LLC (FINRA CRD 281820, a SIPC-member broker-dealer) and is now a wholly-owned Morgan Stanley Wealth Management subsidiary — institutional ownership and distribution, though the underlying SPVs remain limited-disclosure private placements. Equitybee's entity record is also clean: Equitybee Securities LLC (CRD 41896) carries no disclosed FINRA enforcement across 50 states plus DC and PR, and Equitybee Advisors LLC (CRD 309297) reports zero disciplinary events — a fully papered, role-separated structure that deserves credit. But the Equitybee investment vehicles themselves are unaudited, have no independent fund administrator (the affiliated manager administers), and the manager waives fiduciary duties. The disclosure document is a templated PPM, byte-identical across the series family, that does not state the company, price, Share Incentive, or interest rate — those live only on the dashboard and the Form D.
Practical answer
On entity-level regulatory record, both are clean, and Equitybee's structural separation is a genuine positive. On vehicle-level governance, EquityZen's Morgan Stanley ownership and SPV administration sit above Equitybee's unaudited, affiliate-administered, fiduciary-duty-waived series. For an investor who weights independent oversight and audited NAV, that gap matters; for one comfortable self-underwriting each position, it is a diligence input, not a disqualifier.
| Decision factor | What changes |
|---|---|
| Broker-dealer | EquityZen: EquityZen Securities LLC (CRD 281820), SIPC-member, Morgan Stanley-owned. Equitybee: Equitybee Securities LLC (CRD 41896), no disclosed FINRA enforcement across 50 states + DC + PR. |
| Vehicle audit | EquityZen: SPVs are limited-disclosure private placements. Equitybee: series are unaudited, no independent administrator (affiliate-administered). |
| Fiduciary posture | EquityZen: broker-dealer-intermediated marketplace. Equitybee: manager waives fiduciary duties to investors per the PPM. |
| Disclosure document | EquityZen: deal-specific offering documents per SPV. Equitybee: a templated 63-page PPM identical across the series family; deal economics appear only on the dashboard and Form D. |
ROFR + post-IPO lockup vs indefinite, event-contingent hold
Equitybee vs EquityZen: Liquidity & Exit
Neither is liquid, but the failure modes differ. On EquityZen, the deal itself can fail after you commit: the company has a 30+ day ROFR window to buy the shares on your terms or block the transfer entirely, so committed capital may not deploy. If the deal closes, expect 2-5+ years of illiquidity; even after an IPO, fund-held shares can remain restricted until the later of the 180-day lockup expiry or one year from the fund's purchase date. Express Deal resale is conditional and generally unavailable to small-ticket investors. On Equitybee, there is no ROFR risk because no shares are transferred — but there is also no redemption mechanism and no secondary market. The series carry a 7-year term, extendable indefinitely through a Liquidating Vehicle, with a 180+ day post-IPO lockup. Liquidity depends entirely on the portfolio company having a successful liquidity event, which may never occur.
Practical answer
EquityZen's distinctive risk is pre-deployment: ROFR and approval can kill a transaction before your capital is at work. Equitybee's distinctive risk is open-ended duration: no defined exit date and no exit at all if the company never has a successful event. Both should be underwritten as multi-year, illiquid private placements with no dependable early-exit path.
| Decision factor | What changes |
|---|---|
| Deal-completion risk | EquityZen: company ROFR (30+ days) can buy or block after you commit; deals fail post-commitment. Equitybee: no ROFR — no shares transfer — but the funding can be declined before close. |
| Hold period | EquityZen: 2-5+ years typical. Equitybee: 7-year term, extendable indefinitely via a Liquidating Vehicle. |
| Post-IPO reality | EquityZen: restricted until the later of 180-day lockup or one year from fund purchase. Equitybee: 180+ day post-IPO lockup, then distribution on remittance. |
| Early exit | EquityZen: conditional Express Deals (>2% ownership, holding period, single buyer). Equitybee: no redemption and no secondary market for the product. |
Equitybee or EquityZen — which should I use for pre-IPO exposure?
Short answer
They are different instruments, so the question is what you want to hold. If you want an interest in the company's actual shares with the lowest visible fee and institutional backing, EquityZen — accept ROFR, lockup, and K-1 complexity. If you specifically want to finance an employee's option exercise for a capped 17-42% share of the upside and you accept the ~10% fee stack, the unaudited series, and a total-loss floor, Equitybee. For the majority of accredited investors seeking pre-IPO exposure, EquityZen's share-backed structure and 2.5% fee make it the more conventional choice; Equitybee is a specialized instrument for a narrower thesis.
Scenario Analysis
Deploying $10,000–$25,000 into pre-IPO
What each path offers at common accredited allocation sizes — June 2026. All figures platform-reported or primary-source; both are illiquid, accredited-only private placements.
| Metric | EquityZen Single-Company SPV | EquityZen Diversified Fund | Equitybee Series |
|---|---|---|---|
| Minimum | $5,000 floor; $50,000 standard | $20,000 (limited slots) | $10,000 typical (varies) |
| What you own | SPV interest in one company’s shares | SPV interest across multiple companies | A claim on one employee’s proceeds |
| Upfront fee | 2.5% | 2.5% (may add fund costs) | 5% front-end + 5% back-end carry |
| Upside | Full appreciation, net of fees | Full appreciation, diversified, net of fees | Capped: 2-4% interest + 17-42% Share Incentive |
| Downside floor | 100% loss possible; ROFR can block pre-deployment | Diversification softens single-name loss | 0.00x — total loss if no liquidity event |
| Tax document | K-1 (taxable-event years; early March target) | K-1 (annual; late March–April, or Aug–Sept if dual-layer) | K-1 (generally after April 15) |
| Liquidity | 2-5+ yr; post-IPO lockup; conditional Express Deals | Staggered as portfolio exits; multi-year | 7-yr term, extendable indefinitely; no secondary market |
At $10,000–$25,000, an investor wanting share exposure is best served by EquityZen — a single-company SPV for a concentrated thesis or a diversified fund to spread single-name risk, both at 2.5%. Equitybee at the same size buys one or two series’ worth of contingent claims; because each can go to zero and the upside is capped, the structure only makes sense as part of a deliberately diversified basket across many series and vintages, funded with capital that can be locked up with no defined timeframe.
What do the headline numbers — 74% and 70% — actually mean?
Short answer
Both headline figures need adjustment. EquityZen markets a 74% net aggregate exit return — survivorship-biased, excluding ongoing holdings, failures, and time-value, and roughly 11.7% annualized before fees over a five-year hold. Equitybee markets a median 70% discount measured against the most recent preferred price; on 21 live offers (June 2026), the verifiable discount to 409A common is closer to 30% (range ~6-49%). Use ~30% for Equitybee and read 74% as survivorship-adjusted, not expected. Equitybee's own MOIC-by-outcome table shows the asymmetry directly: tender/secondary 2.6x, SPAC 1.7x, IPO 1.6x, M&A 1.5x — and bankruptcy 0.00x.
⚠ Two headline figures, two different adjustments
EquityZen’s platform-stated 74% is an aggregate of exited deals only — it says nothing about the deals that failed or remain locked, and the outcome distribution behind it is not disclosed. Equitybee’s marketed 70% discount uses the most-recent-preferred price as its denominator; the discount relevant to common-equity economics, measured to 409A common on the current live set, is roughly 30%. Neither figure is necessarily wrong on its own terms — both are measured against denominators that flatter them.
| Equitybee outcome (platform-reported MOIC) | Multiple | Notes |
|---|---|---|
| Tender / secondary | 2.6x | Highest reported multiple. Gross of the fee load and the employee-retained Share Incentive. |
| SPAC | 1.7x | Platform-reported, methodology not independently verified. |
| IPO | 1.6x | The most-cited 'success' path; still well below the marketed discount narrative once fees and the Share Incentive are applied. |
| M&A | 1.5x | Acquisition outcome. |
| Bankruptcy | 0.00x | Total loss — 44.8-month average. The floor case the platform discloses directly; interest compounds only on a successful event. |
Why this matters: the two platforms ask you to underwrite fundamentally different payoffs. EquityZen offers uncapped equity upside with a disclosed total-loss tail — the 74% aggregate is real math with missing inputs, and the true question is the undisclosed distribution behind it. Equitybee offers a capped upside (the Share Incentive plus 2-4% interest, net of ~10% fees) against the same zero floor, so the multiples above are gross figures from which the fee stack and the employee’s retained share must still be subtracted. Equitybee’s lifetime track record cannot be independently audited because historical offer-to-company mappings are not publicly recoverable; AltStreet verifies the 21 current live offers and individual Form Ds, and asserts no conclusion about earlier-vintage terms.
Pre-IPO K-1 tax reporting — Equitybee vs EquityZen, which is simpler?
Short answer
Both issue Schedule K-1s because both use partnership-taxed LLC structures, and both can generate phantom income and multi-state filing obligations. Timing differs. EquityZen K-1s vary by vehicle: standard single-company funds issue a K-1 only in taxable-event years (early March target), diversified funds issue annual K-1s (late March to early April), and dual-layer funds can slip to August or September — making an extension functionally the default for some deals. Equitybee K-1s are generally delivered after the April 15 deadline, so an extension should be the default assumption. On an Equitybee event, interest may be treated as ordinary income and the Share Incentive as capital gain; QSBS generally does not apply because you do not hold shares. On EquityZen, QSBS and direct-share treatment are offering-specific. Neither belongs in a standard IRA or HSA without a specialized custodian. Confirm with a qualified tax adviser and the specific deal documents.
Primary sources
Research methodology
Equitybee sources
- ›Form D / Form D/A across the cFund Master series family — ~900 EDGAR CIKs ingested; two series human-verified (FullStory 22-75238, Pie Insurance 22-24416). Form D is templated and company-agnostic. Source ↗
- ›cFund Master Private Placement Memorandum — 63-page template, byte-identical across the series family (209,735 characters); contains no deal-specific economics. Ingested and verified against the source PDF.
- ›Form ADV — Equitybee Advisors LLC (CRD 309297) — Exempt Reporting Adviser via Rule 203(m); $112,494,296 private-fund regulatory AUM (2026-04-01); 582 private funds; zero disciplinary events on Item 11. Source ↗
- ›FINRA BrokerCheck — Equitybee Securities LLC (CRD 41896) — Broker-dealer / placement agent; registered across 50 states + DC + PR; no disclosed FINRA enforcement. Source ↗
- ›Live dashboard capture (21 offers) + 116-page site scrape — Offer price, 409A common price, Share Incentive %, interest %, vintage, minimums (2026-06-21). Verifiable discount to 409A common ~30% (range ~6-49%).
EquityZen sources
- ›150 Form D SPVs across four fund families — Growth Technology Fund LLC, Growth Technology Fund II LLC, Opportunity Funds IV–XI, Thematic Fund LLC (2018–2026). $230.8M raised from 4,848 investors. Source ↗
- ›FINRA BrokerCheck — EquityZen Securities LLC (CRD 281820) — SIPC-member registered broker-dealer subsidiary. Now a wholly-owned Morgan Stanley Wealth Management subsidiary. Source ↗
- ›Morgan Stanley acquisition disclosures (January 2026) — Acquisition closed January 2026; ~$100M integration costs over two years; fee cut to 2.5% buyer/seller effective February 19, 2026.
- ›EquityZen platform materials & Help Center (April 2026) — 850K+ subscribers, 450+ companies, 53K+ approved transactions, $1.5B+ to sellers, $710M+ to investors; 74% platform-stated net aggregate exit return.
- ›Vehicle dossiers & third-party reviews — K-1 timing by vehicle type, ROFR mechanics, Express Deal eligibility, post-IPO lockup terms. AltStreet internal dossier (2026-04-23).
FAQs
Equitybee vs EquityZen: Common questions
What is the difference between Equitybee and EquityZen?+
They are different instruments marketed to the same buyer. EquityZen is a secondary marketplace: it matches an existing shareholder-seller with an accredited buyer and transfers actual company shares, usually wrapped in an SPV LLC whose membership interest you hold. Equitybee is not a secondary market and states so directly — it does not buy or transfer shares. Instead it finances a specific employee's stock-option exercise cost through a single-purpose Series LLC; the employee keeps the shares and contractually owes the series principal, 2-4% annual interest, and a 17-42% share of the funded shares' equity value on a successful liquidity event. On EquityZen you hold an interest in real shares. On Equitybee you hold a contingent claim on one employee's future proceeds — you never appear on the company cap table.
Do I own company shares on Equitybee or EquityZen?+
On EquityZen, yes — indirectly. Most deals are structured through SPV LLCs where you own a membership interest in the entity that holds the underlying shares; larger direct share acquisitions ($200,000+) put your name on the cap table directly. On Equitybee, no. The funded employee remains the 100% legal owner of the shares. Your Series LLC holds a contractual claim on a portion of that employee's proceeds, contingent on a successful liquidity event. The company is not a participant in the Equitybee offering and has not endorsed it.
Which platform has lower fees, Equitybee or EquityZen?+
EquityZen, by a wide margin on the visible cost. Following the January 2026 Morgan Stanley acquisition, EquityZen cut buyer fees to 2.5% on investments up to $1M (2.0% above), with sellers also paying 2.5% — roughly 5% total transaction friction, and no carried interest or ongoing management fee on single-company SPVs. Equitybee carries a 5% front-end brokerage fee on your capital contribution at closing (paid to affiliate Equitybee Securities LLC regardless of outcome), a 5% carried interest on the interest and equity-share portions of proceeds, and a separately-defined Stock Appreciation Amount that the templated PPM names but does not quantify — roughly 10% in platform-level fees before that amount. Separately, the funded employee retains a 17-42% Share Incentive, which is not a fee but caps the portion of equity value the investor receives.
Is Equitybee's 70% discount real?+
It is a platform-reported figure measured against a denominator that makes it read larger. Equitybee's marketed median 70% discount is calculated against the most recent preferred share price paid by cap-table investors, over offers from June 2018 to March 2026, and is hedged by the platform as past performance achieved primarily in favorable conditions. On AltStreet's capture of the 21 current live offers (June 2026), the discount of the offer price to the 409A common price ranged from roughly 6% to 49%, with a median near 30%. Preferred shares carry rights that sit structurally above 409A common, so a preferred-denominated discount reads larger than the discount relevant to common-equity economics. The 70% figure may be accurate on its own terms; the verifiable discount on the current live set is closer to 30%. The lifetime claim cannot be independently audited because historical offer terms are not publicly recoverable.
What does EquityZen's 74% return figure actually mean?+
It is a platform-reported net aggregate exit return across completed deals — and it carries survivorship bias. The figure includes only investments that achieved a successful exit and excludes ongoing holdings, positions that failed entirely, and the opportunity cost of multi-year illiquid capital. Spread over a roughly five-year average hold, 74% is approximately 11.7% annualized before fees, and around 11.1% net of the 2.5% buyer fee. Third-party sources describe individual outcomes ranging from a 100% loss to 450%+ gains. The distribution behind the aggregate — what share of deals lost money, the median outcome, quartile performance by vintage — is not publicly disclosed.
Can I lose all my money on either platform?+
Yes, on both. On Equitybee, repayment is contingent on a successful liquidity event (proceeds exceeding principal) and on the individual employee performing on the remittance obligation. If the company fails or never has a qualifying event, the outcome is total loss — Equitybee's own platform-reported MOIC table lists a 0.00x multiple for the bankruptcy outcome, and interest compounds only on a successful event, so there is no accrual to offset the downside. On EquityZen, a portfolio company can fail and the position can go to zero; separately, a deal can fail before your capital deploys if the company exercises its right of first refusal (ROFR) or blocks the transfer after you have committed. Size every position on either platform assuming it can reach zero.
How long is my capital locked up on Equitybee vs EquityZen?+
Neither offers near-term liquidity, but the lockup mechanics differ. EquityZen positions are typically underwritten as 2-5+ years of illiquidity; even after an IPO, shares held through the fund can remain restricted until the later of the standard 180-day lockup expiry or one year from the fund's purchase date. A conditional Express Deal resale may exist but should not be assumed. Equitybee series carry a 7-year term that is extendable indefinitely through a Liquidating Vehicle, with a 180+ day post-IPO lockup, no redemption mechanism, and no secondary market for the product (Equitybee states this directly). Equitybee capital is committed until the portfolio company has a successful liquidity event — or indefinitely if no event occurs.
How are Equitybee and EquityZen taxed?+
Both generally issue Schedule K-1s because both use partnership-taxed LLC structures, and both can produce phantom income and multi-state filing obligations. The timing differs. EquityZen K-1 timing depends on the vehicle: standard single-company funds often issue a K-1 only in years with a taxable event (targeting early March), diversified managed funds issue annual K-1s (late March to early April), and dual-layer funds can be delayed into August or September — making a tax extension functionally the default for some deals. Equitybee K-1s are generally delivered after the April 15 individual filing deadline, so an extension should be the default assumption. On an Equitybee event, the interest component may generally be treated as ordinary income and the Share-Incentive component as capital gain. QSBS generally does not apply to Equitybee because you do not hold company shares; on EquityZen it is offering-specific. This is not tax advice — consult a qualified adviser and the specific deal documents.
Is EquityZen owned by Morgan Stanley?+
Yes. EquityZen was acquired by Morgan Stanley Wealth Management in January 2026 — reported as the first acquisition under CEO Ted Pick — and now operates as a wholly-owned subsidiary, with Morgan Stanley expecting roughly $100M in integration costs over two years. The acquisition coincided with the fee cut from the prior tiered 5%/4%/3% structure to 2.5% on both buyer and seller sides, effective February 19, 2026. EquityZen continues to operate through its registered broker-dealer subsidiary, EquityZen Securities LLC (FINRA CRD 281820, a SIPC-member broker-dealer). Equitybee, by contrast, is an independent company (Equitybee Inc, founded 2017) operating through affiliated regulated entities.
Which platform is better for first-time pre-IPO investors?+
For an investor who wants exposure to a pre-IPO company's shares with the simpler instrument and the lower visible cost, EquityZen is the more conventional choice: you generally hold an SPV interest backed by actual shares, the fee is 2.5%, and Morgan Stanley ownership adds institutional credibility — with the ROFR, lockup, K-1, and survivorship caveats understood. Equitybee suits a narrower investor who specifically wants the option-funding structure, understands they are buying a contingent claim rather than shares, accepts the ~10% fee stack plus the 17-42% capped upside and the total-loss floor, has read the dashboard terms and the series' Form D rather than relying on the marketed 70% discount, and can build a diversified basket across many series with capital they can lock up indefinitely. Most first-time investors are closer to the first profile than the second.
Are Equitybee's funds audited?+
No. Per the cFund Master Private Placement Memorandum, the Equitybee series LLCs are unaudited, there is no independent fund administrator (administration is handled by the affiliated manager), and the manager waives fiduciary duties to investors. Default statistics, exit statistics, and valuations are self-reported by the affiliated manager without third-party attestation. Importantly, this vehicle-level governance is a separate question from the entity-level regulatory record, which is clean: Equitybee Securities LLC (broker-dealer, CRD 41896) carries no disclosed FINRA enforcement, and Equitybee Advisors LLC (CRD 309297) reports zero disciplinary events on Form ADV Item 11. EquityZen's SPVs are also private placements with limited ongoing disclosure, but the platform now sits under Morgan Stanley's broker-dealer infrastructure.
Can I sell my position early on either platform?+
Rarely, and not dependably, on either. EquityZen offers a conditional Express Deal resale path, but eligibility commonly requires more than 2% ownership of the original fund, satisfaction of minimum holding periods, and finding a single buyer for the full position — investors entering at the $5,000-$20,000 minimums should generally assume it will not be available to them. Equitybee has no redemption mechanism and no secondary market for the product at all. On both platforms, the realistic exit is a company liquidity event, not an early sale.
Full Platform Analysis: Equitybee and EquityZen
Both reviews are sourced from primary documents — SEC Form D filings, the templated cFund Master PPM, Form ADV, FINRA BrokerCheck, Morgan Stanley acquisition disclosures, and direct capture of live offers. No marketing language, no affiliate framing.
Equitybee Full Review
Option-exercise funding mechanics, the templated 63-page PPM, ~10% fee stack, 17-42% Share Incentive, 0.00x floor, ~900 CIKs, and the 70% vs ~30% discount.
EquityZen Full Review
Morgan Stanley acquisition, 2.5% fee cut, SPV structure, 150 Form D vehicles, ROFR and lockup mechanics, K-1 timing, and the 74% survivorship figure.
EquityZen vs Forge vs Hiive
The three major pre-IPO secondary platforms compared — fees, price discovery, ROFR handling, fund structures, and investor fit.
Pre-IPO Access
Full category coverage — secondary marketplaces, SPV access, option-exercise funding, and the access-ladder across Reg D pre-IPO exposure.
